Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04611568 · ClinicalTrials.gov registry record · NA
War on Melanoma™ Public Health & Education Campaign
A NA study of Melanoma, sponsored by OHSU Knight Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 75,000
- Enrollment target
- 1
- Study location
NCT04611568: Recruiting NA study of Melanoma, sponsored by OHSU Knight Cancer Institute.
NCT04611568 is a NA study of Melanoma that is actively recruiting participants, run by OHSU Knight Cancer Institute. The registered enrollment target is 75,000 participants, above the 425-participant average among 266 other Melanoma trials with a reported enrollment target (17547% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04611568, a NA study of Melanoma, is actively recruiting participants, sponsored by OHSU Knight Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 75,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies how well a health educational campaign works in increasing early detection of melanoma in Oregon. The health educational campaign may provide information to help people learn about the early signs of melanoma. Increased education in Oregon may decrease the number of people who die from melanoma and increase the number of melanomas that are identified at an earlier stage.
Primary Outcome
Will compare the level of knowledge and early detection of melanoma between participants in Oregon who received the educational campaign and those who did not in Washington and Utah.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Educational Intervention
- BEHAVIORAL Health Education
- BEHAVIORAL Media Campaign
Study Locations (1)
Oregon
- OHSU Knight Cancer Institute - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75,000 participants |
| Start Date | 2019-05-14 |
| Est. Completion | 2025-12-30 |
| Phase | NA |
What NCT04611568 shows while recruiting
NCT04611568 is an interventional study that assigns participants to a tested intervention. Its 75,000 participants enrollment target places it among the larger protocols in the corpus, above the 425-participant average among 266 other Melanoma trials with a reported enrollment target (17547% higher).
The record links to 1 condition, with Melanoma appearing as the primary indexed condition, and to 4 interventions - of which Survey Administration is the first listed.
NCT04611568 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT04611568 about?
NCT04611568 is a clinical study titled "War on Melanoma™ Public Health & Education Campaign". This trial studies how well a health educational campaign works in increasing early detection of melanoma in Oregon. The health educational campaign may provide information to help people learn about the early signs of melanoma. Increased education in Oregon may decrease the number of people who die...
What is the current status of trial NCT04611568?
This trial is currently recruiting. It is a NA study. The enrollment target is 75,000 participants. The study started on 2019-05-14. Estimated completion is 2025-12-30.
What conditions does trial NCT04611568 study?
This clinical trial studies the following conditions: Melanoma.
What interventions are being tested in trial NCT04611568?
The interventions under investigation include: Survey Administration (OTHER), Educational Intervention (OTHER), Health Education (BEHAVIORAL), Media Campaign (BEHAVIORAL).
Who is sponsoring clinical trial NCT04611568?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04611568 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04611568's enrollment target sits among peer trials
75,000 1st of 266 higher than 266 of 266 other Melanoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Melanoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
RECRUITING · NA
-
Promoting Immunotherapy Efficacy With Low-Dose Liver RT
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
RECRUITING · NA
-
Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
RECRUITING · NA
-
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02402244 · 75,000 participants
Project: Every Child for Younger Patients With Cancer
- NCT02803242 · 75,000 participants
COPD Patient-Powered Research Network
- NCT00063063 · 80,000 participants
Generic Database of Very Low Birth Weight Infants
- NCT06625983 · 80,000 participants · NA
Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI